Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
5.35
-0.09 (-1.65%)
At close: Aug 26, 2026, 4:00 PM EDT
5.35
0.00 (0.00%)
After-hours: Aug 26, 2026, 4:14 PM EDT

Vanda Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
55.8884.85102.32135.82135.0352.07
Short-Term Investments
114.15179272.33252.44331.83380.74
Cash & Short-Term Investments
170.03263.85374.64388.26466.86432.81
Cash Growth
-47.77%-29.57%-3.51%-16.84%7.87%17.70%
Receivables
59.6954.5847.134.1633.5132.47
Inventory
1.681.851.731.361.191.03
Prepaid Expenses
32.9826.8815.429.176.2312
Restricted Cash
0.10.1----
Other Current Assets
----11.5-
Total Current Assets
264.48347.26438.89432.95519.29478.3
Property, Plant & Equipment
23.9513.5112.689.1410.9712.39
Other Intangible Assets
113.12117.09114.1121.3718.5720.08
Long-Term Deferred Tax Assets
--81.447574.0474.88
Other Long-Term Assets
10.9211.089.19.9911.388.15
Total Assets
412.47488.95656.2648.44634.25593.79

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
8.684.943.57.1512.690.93
Accrued Expenses
56.6847.831.3228.9230.5331.2
Current Portion of Leases
4.635.564.272.42.332.31
Other Current Liabilities
94.0386.8760.949.2445.8939.98
Total Current Liabilities
164.03145.1699.9887.791.4474.42
Long-Term Leases
18.27.078.097.018.8110.06
Other Long-Term Liabilities
10.059.539.598.836.84.39
Total Liabilities
192.28161.76117.66103.53107.0588.86

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.060.060.060.060.060.06
Additional Paid-In Capital
725.93721.26712.71700.27686.24669.22
Retained Earnings
-505.85-394.77-174.29-155.39-157.9-164.18
Comprehensive Income & Other
0.040.630.07-0.03-1.19-0.18
Shareholders' Equity
220.19327.19538.55544.91527.2504.93
Total Liabilities & Equity
412.47488.95656.2648.44634.25593.79

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
22.8312.6212.369.411.1412.37
Net Cash (Debt)
147.2251.23362.28378.86455.72420.45
Net Cash Growth
-53.11%-30.65%-4.38%-16.86%8.39%18.73%
Net Cash Per Share
2.484.266.236.588.007.39
Filing Date Shares Outstanding
60.4659.1158.3257.5456.7955.91
Total Common Shares Outstanding
60.4559.158.3157.5356.7855.9
Working Capital
100.46202.1338.91345.25427.86403.88
Book Value Per Share
3.645.549.249.479.289.03
Tangible Book Value
107.07210.1424.45423.54508.63484.85
Tangible Book Value Per Share
1.773.557.287.368.968.67
Machinery
-9.378.237.787.587.03
Leasehold Improvements
-5.55.475.445.425.46
SEC Filings: 10-K · 10-Q